2025-05-14T17:56:59-05:00 2024-12-31 410746749 CLIFTONLARSONALLEN LLP TWO INTERNATIONAL PLACE 22ND FLOOR BOSTON MA 02110 990 2024-01-01 131949477 NEW YORK BLOOD CENTER INC NEWY 2125703000 601 MIDLAND AVE RYE NY 10580 DAVID BENCH CFO 2125703100 2025-05-13 1 0 LAURA J KENNEY P00202198 6177170831 2025-05-13 2024 2025-03-06 01:10:19Z X DR CHRISTOPHER D HILLYER 601 MIDLAND AVE RYE NY 10580 653233827 0 X NYBC.ORG X 1959 NY AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NEW YORK BLOOD CENTER OPERATES UNDER A FOUR-PART MISSION.SPECIFICALLY, NYBC EXISTS:- TO PROVIDE THE HIGHEST QUALITY BLOOD AND STEM CELL PRODUCTS AND RELATED MEDICAL AND CONSULTATIVE SERVICES TO HOSPITALS AND PATIENTS.- TO CONDUCT THE HIGHEST QUALITY, NOVEL AND INNOVATIVE RESEARCH IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING AND TRANSFUSION MEDICINE, AND CELLULAR THERAPIES, THUS ADVANCING THESE FIELDS AND POSITIVELY IMPACTING THE PUBLIC HEALTH- TO DEVELOP PRODUCTS, TECHNOLOGIES, AND SERVICES IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING, AND TRANSFUSION MEDICINE AND CELLULAR THERAPIES, WITH THE POTENTIAL TO HAVE WORLDWIDE HUMANITARIAN IMPACT- TO TRAIN THE NEXT GENERATION OF LEADERS IN EACH OF THESE FIELDS 17 16 3358 750 0 0 21586173 15901132 540724626 582247663 -555884 4911840 3064027 2710329 564818942 605770964 137280 255427 0 0 237169221 267607598 0 0 789112 362220673 384874206 599527174 652737231 -34708232 -46966267 784292844 884660660 226434295 329176524 557858549 555484136 AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THEWORLD, NYBC OPERATES UNDER A FOUR-PART MISSION. FOR MORE INFORMATION,SEE SCH. O AND PART III, 4A-C. 0 0 312255204 255427 393591541 BLOOD SERVICES: THE COLLECTION AND PROCESSING OF BLOOD PRODUCTS,TESTING OF BLOOD SAMPLES AND THE DISTRIBUTION OF THESE PRODUCTS TOHOSPITALS IN THE REGIONS SERVED BY NYBCE DIVISIONS. 178665775 188656122 MEDICAL PROGRAMS: (1) HEMOPHILIA SERVICES CONSORTIUM,(2) COMPREHENSIVE CELL SOLUTIONS (INCLUDES APHERESIS/TRANSFUSION SERVICES AND CONTRACT MANUFACTURING), (3) BONE MARROW PROGRAM, AND (4) NATIONAL CORD BLOOD PROGRAM (COLLECTION, PROCESSING, AND STORAGE OF CORD BLOOD UNITS AND DISTRIBUTION OF THESE UNITS FOR TREATMENT OR RESEARCH PURPOSES) 15374148 RESEARCH PROGRAM: THE NEW YORK BLOOD CENTER OPERATES AWIDE-RANGING PROGRAM OF RESEARCH INTO THE PROPERTIES OF BLOOD ANDBLOOD RELATED DISEASES. 506295127 1 1 0 1 0 0 0 0 0 0 1 1 0 1 1 1 1 1 0 0 1 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 1 0 0 0 1 0 0 0 0 1 X 325 0 1 3358 1 1 0 0 0 0 0 0 0 0 0 0 1 0 X 17 16 0 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA FL IL MA MD MI MN NC NJ NY PA RI TN VA WI X DAVID BENCH 2125703440 601 MIDLAND AVE RYE NY 10580 CHRISTOPHER D HILLYER PRESIDENT & CHIEF EXECUTIVE OFFICER 50.00 X X 2527854 0 116488 AVERY AUGUST TRUSTEE 1.00 X 0 0 0 JUNG CHOI TRUSTEE 1.00 X 0 0 0 YVES DENIZE TRUSTEE 1.00 X 0 0 0 DAVID DRISCOLL TRUSTEE 1.00 X 0 0 0 PHILIP J FALIVENE TRUSTEE 1.00 X 0 0 0 JOHN FERRETTI TRUSTEE 1.00 X 0 0 0 ARIEL FISHMAN TRUSTEE 1.00 X 0 0 0 OWEN GARRICK TRUSTEE 1.00 X 0 0 0 MARC KRAMER TRUSTEE 1.00 X 0 0 0 AARON R MARCU TRUSTEE 1.00 X 0 0 0 THERESA RAGOZINE TRUSTEE 1.00 X 0 0 0 JOHN L ROSENTHAL TRUSTEE 1.00 X 0 0 0 MARK SCHMIDTLEIN TRUSTEE 1.00 X 0 0 0 ROBERT A SCHWARTZ TRUSTEE 1.00 X 0 0 0 JAIME SHAMONKI TRUSTEE 1.00 X 0 0 0 PAUL M TORGERSON TRUSTEE 1.00 X 0 0 0 BERNADETTE TISO VP, DEPUTY GENERAL COUNSEL/ASST SEC 50.00 X 306270 0 64144 BETSY JETT SVP, QUALITY AND REGULATORY AFFAIRS 50.00 X 517712 0 45782 BRUCE SACHAIS SVP, CHIEF MEDICAL OFFICER 50.00 X 439367 0 58524 DAVID BENCH EVP, CHIEF FINANCIAL OFFICER 50.00 X 632962 0 85814 JORDANA SCHWARTZ SVP - GENERAL COUNSEL/SECRETARY 50.00 X 534976 0 76668 JOSEPH MOHR EVP, CHIEF BUSINESS OFFICER 50.00 X 866948 0 78071 SHAKIMA WELLS SR. ASSOC GENERAL COUNSEL/ASST SEC 50.00 X 209473 0 43493 ADRIAN DAVID EVP, CHIEF OPERATING OFFICER 50.00 X 586452 0 35741 LARRY LUCHSINGER SVP, CHIEF SCIENTIFIC OFFICER 50.00 X 351498 0 44793 RICHARD KIERNAN SVP, CHIEF HUMAN RESOURCES OFFICER 50.00 X 426218 0 56116 VAUGHN RATCHFORD SVP, CHIEF REAL ESTATE OFFICER 50.00 X 477427 0 72796 SHILPI BANERJEE SVP, GENERAL COUNSEL AND SECRETARY 50.00 X 41052 0 1143 ANDREA CEFARELLI SVP, CORPORATE COMM & PUBLIC AFFAIRS 50.00 X 401362 0 41722 DAVID GRAHAM SVP ENTERPRISE DONOR ENGAGEMENT 50.00 X 421850 0 66523 DONNA STRAUSS VP - ENTERPRISE LABORATORY SERVICES 50.00 X 435711 0 64424 ERIC SENALDI DEPUTY CHIEF MEDICAL OFFICER 50.00 X 345859 0 66416 JED GORLIN VP, MEDICAL & REGULATORY AFFAIRS 50.00 X 797834 0 48641 JONATHAN BARBA VP, INFORMATION TECHNOLOGY 50.00 X 322754 0 37322 MAHTAB KHAN VICE PRESIDENT OF FINANCE 50.00 X 337939 0 43881 MONIQUE BROWN GEORGE VP, HUMAN RESOURCES 50.00 X 324653 0 38313 PATRICIA KILLEEN SVP, LOGISTICS, OPS EXCELLENCE 50.00 X 424273 0 59127 RICHARD YOUNGBLOOD SVP, CHIEF OF STAFF 50.00 X 334671 0 42722 PATRICIA SHI VP, MEDICAL DIRECTOR 50.00 X 305077 0 59910 KARINA YAZDANBAKHSH VP, DIRECTOR OF RESEARCH LFKRI 50.00 X 332540 0 32759 MEGHAN WOOD VP, VENTURES & BUSINESS DEVELOPMENT 50.00 X 430660 0 69425 KATHRYN GEIST VP, REGIONAL OPERATIONS (IBR & CBC) 50.00 X 319472 0 50867 JEANNIE MASCOLINO VP, REGIONAL OPERATIONS (NYBC) 50.00 X 392412 0 65757 DEVIN BLASS SVP, COMPREHENSIVE CELL SOLUTIONS 50.00 X 337981 0 39673 ELIZABETH MCQUAIL EVP - OPS & MANUFACTURING/COO 0.00 X 492691 0 0 14675948 0 1607055 544 1 1 0 CONSIGLI CONSTRUCTION CO INC 72 SUMMER STREET MILFORD ME 01757 CONSTRUCTION 71982326 MARKHAM AND STEIN UNLIMITED LLC 2424 SOUTH DIXIE HIGHWAY MIAMI FL 33133 MARKETING SERVICES 4634263 INCEPT CORPORATION 4150 BELDEN VILLAGE ST CANTON OH 44718 BLOOD DONOR MARKETING 3736261 DONALD HOLM CONSTRUCTION 3211 W 3RD STREET DULUTH MN 55806 CONSTRUCTION 1766557 CENTURY PROTECTIVE SERVICES 150 GRAND STREET WHITE PLAINS NY 10601 SECURITY SERVICES 1741913 73 13112899 2788233 444126 15901132 BLOOD SERVICES 621500 393591541 393591541 MEDICAL PROGRAMS 621500 188656122 188656122 582247663 989570 989570 3546 3546 883318 0 883318 883318 883318 51265000 120133 47462863 0 3802137 120133 3922270 3922270 REBATES & MISCELLANEOU 1823465 1823465 1823465 605770964 584071128 0 5798704 8221 8221 247206 247206 16470087 1976410 14493677 27732 25941 1791 189946586 150026939 39404967 514680 17560429 15820491 1725598 14340 30615564 24760612 5796071 58881 12987200 10299325 2649148 38727 3005469 363204 2642265 183259 183259 252000 252000 2840555 2840555 22739974 9156005 13563100 20869 4505740 4281508 224232 4711038 1252126 3457382 1530 12764046 443176 12312610 8260 21625301 35949 21589352 3348583 2759564 586028 2991 380297 39651 340646 16535900 7740320 8763457 32123 4110557 413574 3696983 SUPPLIES 232394416 231350673 1028284 15459 R&M & EQUIPMENT 18811946 10900463 7910128 1355 MGMT FEE-HEMOPHILIA CON 13083505 13083505 COURIER/DELIVERY SERVIC 7839915 7806627 33288 15741705 13503637 2158171 79897 652737231 506295127 145652992 789112 19694640 43148 10146571 30306781 75529876 95829028 32198740 33878586 6936330 5716694 458616652 257032955 111880949 201583697 1133740 817949 382875614 385528382 1813476 2134677 142082908 128821718 784292844 884660660 68734975 82621893 49933729 2968781 24362273 10500000 154730539 161758629 226434295 329176524 X 551603592 548955428 6254957 6528708 557858549 555484136 784292844 884660660 -46966267 44591854 0 X 0 1 X 1 1 1 X 24165905 12767729 16625619 21586173 15901132 91046558 528661629 376487315 522931505 542547064 584071128 2554698641 552827534 389255044 539557124 564133237 599972260 2645745199 44804 28000 43525 43500 34749 194578 186892859 196996315 383889174 44804 28000 43525 186936359 197031064 384083752 2261661447 1550871 1413224 2126061 3591559 1876434 10558149 1550871 1413224 2126061 3591559 1876434 10558149 554378405 390668268 541683185 567724796 601848694 2656303348 0.85140 0.91950 0.00400 0.00600 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 252000 252000 652485231 652737231 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 664413 255590 402959 252000 1574962 250000 250000 250000 250000 1000000 1500000 17121175 17121175 125912700 90110793 35801907 123774541 87202997 36571544 191808236 79719165 112089071 201583697 INVESTMENT FUNDS 385528382 F 385528382 SECURITY DEPOSITS HELD BY LANDLORDS 508342 RIGHT OF USE ASSET 127108171 ASSETS SCHEDULED TO CONVERT TO LEASE 1205205 128821718 CAPITAL LEASES - RIGHT OF USE LIABILITY 159725101 FMV OF INTEREST RATE SWAP 1207 TENANT SECURITY DEPOSITS 44665 OTHER CURRENT LIABILITIES 1987656 161758629 X 647262423 44591854 120000 44711854 602550569 2840555 379840 3220395 605770964 649636836 120000 120000 649516836 2840555 379840 3220395 652737231 PART X, LINE 2: NYBCE HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE TO BE EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC) AND IS GENERALLY EXEMPT FROM STATE AND LOCAL INCOME TAXES, EXCEPT ON ANY INCOME GENERATED FROM ACTIVITIES UNRELATED TO NYBCE'S EXEMPT PURPOSE. NYBCE HAS ADOPTED THE PROVISIONS OF FASB INTERPRETATION NO. 48, ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES (FIN 48). FIN 48 CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES RECOGNIZED IN AN ORGANIZATION'S FINANCIAL STATEMENTS AND PRESCRIBES A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR THE FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. NYBCE RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. MANAGEMENT HAS DETERMINED THERE ARE NO UNCERTAIN TAX POSITIONS FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023. VENTURES IS A SINGLE MEMBER LLC AND IS TREATED AS A DISREGARDED ENTITY FOR FEDERAL INCOME TAX PURPOSES. VENTURES IS WHOLLY OWNED BY NYBCE. PART XI, LINE 4B - OTHER ADJUSTMENTS: RECLASSIFICATIONS BETWEEN REVENUES AND EXPENSES 379,840. PART XII, LINE 4B - OTHER ADJUSTMENTS: RECLASSIFICATIONS BETWEEN REVENUES AND EXPENSES 379,840. CENTRAL AMERICA AND THE CARIBBEAN INVESTMENTS 2419136 0 0 0 0 0 0 2419136 0 2419136 0 0 1 1 1 0 1 SCHOLARSHIPS 532 247206 PART III COLLEGE SCHOLARSHIPS ARE AWARDED TO STUDENTS WHO VOLUNTEER THEIR TIME AT BLOOD DRIVES IN THE FURTHERANCE OF NYBC'S MISSION. X X X X X 1 1 0 0 0 0 0 1 0 CHRISTOPHER D HILLYER PRESIDENT & CHIEF EXECUTIVE OFFICER 1218392 0 1205000 0 104462 0 87580 0 28908 0 2644342 0 47950 0 JOSEPH MOHR EVP, CHIEF BUSINESS OFFICER 652299 0 167375 0 47274 0 47892 0 30179 0 945019 0 15789 0 JED GORLIN VP, MEDICAL & REGULATORY AFFAIRS 361128 0 26945 0 409761 0 17250 0 31391 0 846475 0 0 0 DAVID BENCH EVP, CHIEF FINANCIAL OFFICER 541745 0 82500 0 8717 0 39344 0 46470 0 718776 0 0 0 ADRIAN DAVID EVP, CHIEF OPERATING OFFICER 503639 0 50000 0 32813 0 21331 0 14410 0 622193 0 0 0 JORDANA SCHWARTZ SVP - GENERAL COUNSEL/SECRETARY 466635 0 47000 0 21341 0 33543 0 43125 0 611644 0 10639 0 BETSY JETT SVP, QUALITY AND REGULATORY AFFAIRS 450706 0 44600 0 22406 0 31927 0 13855 0 563494 0 8908 0 VAUGHN RATCHFORD SVP, CHIEF REAL ESTATE OFFICER 407879 0 61800 0 7748 0 29472 0 43324 0 550223 0 0 0 DONNA STRAUSS VP - ENTERPRISE LABORATORY SERVICES 368432 0 37642 0 29637 0 38771 0 25653 0 500135 0 0 0 MEGHAN WOOD VP, VENTURES & BUSINESS DEVELOPMENT 365877 0 64093 0 690 0 26674 0 42751 0 500085 0 0 0 BRUCE SACHAIS SVP, CHIEF MEDICAL OFFICER 382624 0 39800 0 16943 0 28467 0 30057 0 497891 0 0 0 ELIZABETH MCQUAIL EVP - OPS & MANUFACTURING/COO 0 0 0 0 492691 0 0 0 0 0 492691 0 0 0 DAVID GRAHAM SVP ENTERPRISE DONOR ENGAGEMENT 342227 0 53938 0 25685 0 26272 0 40251 0 488373 0 0 0 PATRICIA KILLEEN SVP, LOGISTICS, OPS EXCELLENCE 358047 0 37911 0 28315 0 27403 0 31724 0 483400 0 0 0 RICHARD KIERNAN SVP, CHIEF HUMAN RESOURCES OFFICER 395925 0 24400 0 5893 0 12696 0 43420 0 482334 0 0 0 JEANNIE MASCOLINO VP, REGIONAL OPERATIONS (NYBC) 362689 0 27058 0 2665 0 34500 0 31257 0 458169 0 0 0 ANDREA CEFARELLI SVP, CORPORATE COMM & PUBLIC AFFAIRS 341279 0 27000 0 33083 0 36840 0 4882 0 443084 0 0 0 ERIC SENALDI DEPUTY CHIEF MEDICAL OFFICER 319064 0 24157 0 2638 0 33175 0 33241 0 412275 0 0 0 LARRY LUCHSINGER SVP, CHIEF SCIENTIFIC OFFICER 316382 0 27500 0 7616 0 21740 0 23053 0 396291 0 0 0 MAHTAB KHAN VICE PRESIDENT OF FINANCE 313399 0 23057 0 1483 0 22222 0 21659 0 381820 0 0 0 DEVIN BLASS SVP, COMPREHENSIVE CELL SOLUTIONS 291529 0 27000 0 19452 0 125 0 39548 0 377654 0 0 0 RICHARD YOUNGBLOOD SVP, CHIEF OF STAFF 284305 0 0 0 50366 0 22707 0 20015 0 377393 0 0 0 BERNADETTE TISO VP, DEPUTY GENERAL COUNSEL/ASST SEC 284329 0 21393 0 548 0 20797 0 43347 0 370414 0 0 0 KATHRYN GEIST VP, REGIONAL OPERATIONS (IBR & CBC) 295422 0 21866 0 2184 0 4699 0 46168 0 370339 0 0 0 KARINA YAZDANBAKHSH VP, DIRECTOR OF RESEARCH LFKRI 307883 0 22499 0 2158 0 30899 0 1860 0 365299 0 0 0 PATRICIA SHI VP, MEDICAL DIRECTOR 295816 0 7886 0 1375 0 21421 0 38489 0 364987 0 0 0 MONIQUE BROWN GEORGE VP, HUMAN RESOURCES 300821 0 22397 0 1435 0 21531 0 16782 0 362966 0 0 0 JONATHAN BARBA VP, INFORMATION TECHNOLOGY 300127 0 22217 0 410 0 21412 0 15910 0 360076 0 0 0 SHAKIMA WELLS SR. ASSOC GENERAL COUNSEL/ASST SEC 200998 0 8179 0 296 0 14742 0 28751 0 252966 0 0 0 PART I, LINES 4A-B THE FOLLOWING INDIVIDUALS RECEIVED SEVERANCE PAYMENTS IN 2024 IN ACCORDANCE WITH THEIR AGREEMENTS WITH THE ORGANIZATION: - ELIZABETH MCQUAIL - $492,691 - RICHARD YOUNGBLOOD - $14,286 THE ORGANIZATION HAS A SECTION 457(F) PLAN FOR ITS CEO, CHRISTOPHER D. HILLYER, AND THE OTHER PARTICIPANTS LISTED BELOW. SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN BENEFITS ACCRUED BEFORE 2024 WERE VESTED AND PAID TO PARTICIPANTS IN 2024 AS FOLLOWS: - CHRISTOPHER HILLYER - $47,950 - JORDANA SCHWARTZ - $10,369 - BETSY JETT - $8,908 - JOSEPH MOHR - $15,789 NEW PLAN BENEFITS FOR THE PARTICIPANTS IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN WERE ACCRUED IN 2024 AS FOLLOWS: - CHRISTOPHER HILLYER - $63,430 - JORDANA SCHWARTZ - $9,393 - BETSY JETT - $7,777 - JOSEPH MOHR - $23,742 - ANDREA CEFARELLI - $2,340 - BRUCE SACHAIS - $4,317 - DAVID GRAHAM - $2,122 - DONNA STRAUSS - $4,271 - PATRICIA KILLEEN - $3,253 - DAVID BENCH - $15,194 - VAUGHN RATCHFORD - $5,322 - MEGHAN WOOD - $2,524 - ADRIAN DAVID - $9,529 - RICHARD KIERNAN - $3,188 NEW PLAN BENEFITS ACCRUED IN 2024 ARE SUBJECT TO A THREE YEAR VESTING SCHEDULE WHICH IS A SUBSTANTIAL RISK OF FORFEITURE. PLAN BENEFIT AMOUNTS THAT BECOME VESTED TO PARTICIPANTS ARE INCLUDED IN THE TOTALS REPORTED IN SCHEDULE J, PART II, COLUMN (B)(III). NEW ACCRUALS OF PLAN BENEFITS ARE INCLUDED IN THE TOTALS REPORTED IN SCHEDULE J, PART II, COLUMN (C). PART I, LINE 7 UPON THE ORGANIZATION ACHIEVEING CERTAIN BUDGET THRESHOLDS, EXECUTIVES OTHER THAN THE CEO WERE ELIGIBLE FOR MERIT BONUSES OF UP TO 10% OF THEIR ANNUAL BASE SALARIES, DETERMINED BY THEIR ACHIEVING PERFORMANCE BENCHMARKS ESTABLISHED BY SENIOR MANAGEMENT AND APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD. THE CEO'S ANNUAL BONUS IS DISCRETIONARY DETERMINED BY THE BOARD AND BASED ON PERFORMANCE. A WESTCHESTER COUNTY LOCAL DEVELOPMENT FUND CORPORATION 455135576 95737TFT8 2024-01-24 51120737 RENOVATION OF 601 MIDLAND AVE RYE NY 0 0 0 A 51122081 1119393 39295992 10705352 2025 0 0 0 0 A 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 A 0 1 1 0 0 0 0 0 1 A 1 PART I, LINE A, COLUMN (E) AND PART II, LINE 3, COLUMN A: THE TOTAL PROCEEDS OF ISSUE PER PART II, LINE 3, COLUMN A EXCEEDS THE BOND ISSUE PRICE PER PART I, LINE A, COLUMN (E) BY $1,344. THE AMOUNT IS INTEREST PROCEEDS. JACKSON HILLYER SON OF CEO 25941 EMPLOYMENT 0 X 25 390728 COST X PROMO ITEMS 119 53398 COST 0 1 0 990 SCHEDULE M PART I COLUMN (B) THE NUMBER OF NON-CASH CONTRIBUTIONS RECEIVED IS REPORTED IN COLUMN (B). FORM 990, PART V, LINE 3B NEW YORK BLOOD CENTER INC. WILL REQUEST AN EXTENSION OF TIME TO FILE 2024 FORM 990-T. FORM 990, PART VI, SECTION A, LINE 1A THE BOARD MAY DESIGNATE STANDING COMMITTEES FROM AMONG ITS MEMBERS. THESE COMMITTEES INCLUDE AN EXECUTIVE COMMITTEE COMPRISED OF THE CHAIR, VICE CHAIR AND THE CHAIR OF EACH OF THE STANDING COMMITTEES OF THE BOARD. THE EXECUTIVE COMMITTEE MAY EXERCISE BOARD POWERS IN BETWEEN MEETINGS OF THE BOARD. FORM 990, PART VI, SECTION A, LINE 4 NEW YORK BLOOD CENTER INC. ESTABLISHED NYBC VENTURES, LLC, A WHOLLY OWNED ENTITY THAT IS A DISREGARDED ENTITY FOR TAX PURPOSES, SHARING ITS BYLAWS. FORM 990, PART VI, SECTION B, LINE 11B FOLLOWING COMPLETION OF THE FINANCIAL STATEMENT AUDIT, THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM WITH THE INFORMATION PROVIDED BY MANAGEMENT, AND REVIEWED AND APPROVED BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. THE FINAL FORM 990 IS THEN CIRCULATED TO THE FULL BOARD FOR REVIEW PRIOR TO BEING FILED WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C EACH YEAR, AND ON AN AS-NEEDED BASIS, THE ORGANIZATION REQUIRES ALL TRUSTEES, OFFICERS, KEY EMPLOYEES, AND SENIOR EXECUTIVES TO COMPLETE AND SIGN A STATEMENT DISCLOSING ANY ACTUAL OR APPARENT CONFLICT OF INTEREST. THESE STATEMENTS ARE REVIEWED BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD, AS WELL AS BY THE CEO AND THE GENERAL COUNSEL. THE BOARD ULTIMATELY WILL DETERMINE WHETHER ANY CONFLICT OF INTEREST EXISTS, AND IF SO, IT APPOINTS A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE AND DETERMINE HOW TO MANAGE ANY SUCH CONFLICT. IN ADDITION, THE ORGANIZATION MAINTAINS A GENERAL CONFLICT OF INTEREST POLICY THAT APPLIES TO ALL EMPLOYEES. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION'S ANNUAL PROCESS FOR DETERMINING COMPENSATION OF ITS CEO INCLUDED REVIEW AND APPROVAL BY THE INDEPENDENT COMPENSATION AND EXECUTIVE COMMITTEES OF THE BOARD AND BY THE FULL BOARD, AS WELL AS ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, AND FORMS 990 OF OTHER ORGANIZATIONS. ALL COMPENSATION REVIEW PROCESSES ARE CONTEMPORANEOUSLY DOCUMENTED. FOR DETERMINING COMPENSATION OF ITS OTHER OFFICERS AND ITS KEY EMPLOYEES, THE ORGANIZATION USED ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, REVIEW BY THE CEO AND APPROVAL BY THE INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS, GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND CODE OF CONDUCT AVAILABLE UPON REQUEST. NYBC VENTURES LLC 420 BOYLSTON STREET SUITE 501 BOSTON MA 02116 INVESTMENTS CONSISTENT WITH FUND INVESTMENT POLICY DE 15929713 NEW YORK BLOOD CENTER INC